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Background: Use of electronic health records for ascertainment of disease outcomes in large 
population-based studies holds much promise due to low costs, diminished study participant 
burden, and reduced selection bias. However, the validity of cardiovascular disease endpoints 
derived from electronic records is unclear. 
Methods: Participants were 7860 study members of the UK Whitehall II cohort study. We 
compared cardiovascular disease ascertainment using linkage to the National Health Service’s 
Hospital Episode Statistics database records (hereafter, ‘HES-ascertainment’) against repeated 
biomedical examinations - our gold-standard ascertainment method (‘Whitehall-ascertainment’). 
Follow-up for both methods was from 1997 to 2013 for coronary heart disease and from 1997 to 
2009 for stroke. 
Results: We identified 950 prevalent or incident non-fatal coronary heart disease cases and 118 
prevalent or incident non-fatal stroke cases using Whitehall-ascertainment. The corresponding 
figures for HES ascertainment were 926 and 107. For coronary heart disease, the sensitivity of 
HES-ascertainment was 70%, positive predictive value 72%, specificity 96%, and the negative 
predictive value 96%. The pattern of results for stroke was similar. These statistics did not differ 
in analyses stratified by age, sex, baseline risk factor status, or after exclusion of prevalent cases. 
Estimates of risk factor-disease associations were similar between the two ascertainment 
methods. Including fatal cardiovascular disease in the outcomes improved the agreement between 
the methods. 
Conclusion: Our analyses support the validity of cardiovascular disease ascertainment using 
linkage to the UK Hospital Episode Statistics database records by showing agreement with high 
resolution disease data collected in the Whitehall II cohort. 
Keywords: Coronary heart disease; stroke; electronic health records; validation
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INTRODUCTION 
Accurate ascertainment of disease endpoints is a key tenet of epidemiology.  In well-
characterized cohort studies of disease etiology, such as Framingham (US) and the Whitehall II study 
(UK), disease outcomes are ascertained using serial biomedical evaluations of the participants.
1-3
 In 
contrast to this resource-intensive method, current ‘big data’ approaches capitalize on linkage to 
routinely collected electronic health records to identify incident and prevalent disease.
4
 Data linkage 
holds much promise due to lower costs, reduced study participant burden, and diminished selection 
bias.
5,6
 However, the validity of routinely collected records is unclear.  
  In this study, we used repeated biomedical examinations from the Whitehall II study as the gold-
standard for ascertainment of cardiovascular disease (hereafter, ‘Whitehall-ascertainment’),7,8 
comparing this against disease ascertainment using linkage of study members to the UK National 
Health Service’s Hospital Episode Statistics (HES) database records (hereafter, ‘HES-ascertainment’). 
METHODS 
Study Population 
The source population of the British Whitehall II study was all London-based, non-industrial 
government workers, aged 35-55 years, working in 20 departments at study baseline in 1985-8. With a 
response of 73%, the baseline cohort consisted of 10 308 employees (6895 men and 3413 women). 
Ethical approval for the Whitehall II study, including linkage to HES and mortality records, was 
obtained from University College London Medical School committee on the ethics of human research 
(reference number 85/0938), and the London-Harrow and Scotland A Research Ethics Committees on 
the Ethics of Human Research. All participants provided written informed consent. 
The health care system in the United Kingdom, National Health Service (NHS), is funded from 
taxation to provide comprehensive health care coverage available to all individuals legally registered 
as residents in the United Kingdom. All UK citizens have a unique NHS identification number. The 
HES is an administrative NHS database containing details of all admissions, outpatient appointments 
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and accident and emergency attendances at NHS hospitals. Hospitals are paid for the care they deliver 
based on clinical information from HES about diagnoses and procedures. HES data are also used for 
healthcare planning, commissioning services, development of national policy, and research 
(http://content.digital.nhs.uk/hes). The Office of National Statistics, the recognized national statistical 
institute in the United Kingdom, maintains vital events data, including records of deaths occurring 
anywhere in the United Kingdom, and for research purposes these records are distributed by NHS 
Digital. 
Design 
Both Whitehall- and HES-ascertained events were available from the 3
rd
 (Clinic 3) to the 6
th
 
clinical examination (Clinic 6) for coronary heart disease, and from Clinics 3 to 5 for stroke. Clinic 3 
(1997-1999) represents the baseline for the present study, with subsequent examinations taking place 
in 2003-2004 (Clinic 4), 2008-2009 (Clinic 5), and 2012-2013 (Clinic 6). 
Baseline Characteristics 
Demographic characteristics (age, gender, 3-level socioeconomic status), smoking (current, ex-, 
never smoker), hypertension (systolic blood pressure ≥140mmHg, diastolic blood pressure ≥90mmHg 
or on antihypertensive medication), and high cholesterol (total cholesterol ≥6mmol/L or on lipid-
lowering medication) were measured using standard protocols.
3
 
Ascertainment of Coronary Heart Disease 
Whitehall-ascertained non-fatal coronary heart disease was based on 12-lead resting ECG 
recording, coded using the Minnesota system, and on self-reported coronary heart disease that had 
been corroborated with information from the general practitioner or by manual retrieval of hospital 
records. The ascertainment included non-fatal myocardial infarction, definite angina, reported 
coronary artery bypass grafting and percutaneous transluminal coronary angioplasty.
7
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HES-ascertainment was based on data linkage to records from hospitalizations for non-fatal coronary 
heart disease as a primary or secondary diagnosis (defined using ICD-9 codes 410-414, ICD-10 codes 
I20-I25, or procedures K40-K49, K50, K75, U19), by using the NHS identification number.  
The main outcome was the first incident or recurrent non-fatal coronary heart disease event after 
baseline. To capture both non-fatal and fatal coronary heart disease in a subsidiary analysis, records of 
coronary death (defined using ICD-9 codes 410-414 and ICD-10 codes I20-I25) were added to both 
ascertainment methods. Death records were obtained from data linkage to the Office of National 
Statistics death registry by using the NHS identification number, and the data included death date and 
the underlying cause. 
Ascertainment of Stroke 
Whitehall ascertainment for non-fatal stroke was based on self-reported diagnosis and use of 
MONICA-Ausburg stroke questionnaires that capture symptoms associated with events, even if the 
participant did not report having had a diagnosis. If a participant responded positively to at least one of 
these, their histories were corroborated with the general practitioner’s confirmation, HES data linkage 
(ICD codes in HES ascertainment), or manual retrieval of hospital medical records reviewed by a 
stroke clinician.
8
  
HES-ascertainment was based on data linkage to electronic records from hospitalisations due to 
stroke as a primary or secondary diagnosis (defined using ICD-9 codes 430, 431, 434, 436 and ICD-
10-cased I60, I61, I63, I64).  
The first incident or recurrent non-fatal stroke after baseline was the main outcome. As in 
relation to coronary heart disease, fatal or non-fatal stroke was an additional outcome; records from 
data linkage to the Office of National Statistics death registries (the same ICD-codes) were added to 
both ascertainment methods. 
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Statistical Methods 
To examine the validity of HES-ascertained coronary heart disease and stroke using Whitehall-
ascertainment as the gold standard, we computed the sensitivity (the proportion of Whitehall-
ascertained cases that are detected with HES-ascertainment), specificity (the proportion of participants 
without Whitehall-ascertained disease who have no HES-ascertained disease), positive predictive 
value (the proportion of participants with HES-ascertained disease that are Whitehall-ascertained 
cases), and negative predictive value (the proportion of participants without HES-ascertained disease 
that are Whitehall-ascertained non-cases). These statistics with 95% confidence intervals were 
computed separately for incident/recurrent non-fatal events and fatal/non-fatal events as the outcome. 
The results were reported for the total cohort and by age group (<55, 55-59, >60 years), sex, 
socioeconomic status, smoking, hypertension, hypercholesterolemia and period of follow-up (from 
Clinic 3 to Clinic 4, from Clinic 4 to Clinic 5, and from Clinic 5 to Clinic 6), and after excluding 
prevalent cases of coronary heart disease and stroke at baseline. We also computed age- and sex-
adjusted associations of risk factors (age, sex, socioeconomic status, smoking, high blood pressure, 
high cholesterol) with coronary heart disease and stroke using the two methods of disease 
ascertainment. 
RESULTS 
A total of 7855 study members (76.2% of the 10,308 initial study members) participated in 
Clinic 3 and had follow-up for coronary heart disease based on both the Whitehall- and the HES-
ascertainment. The corresponding number for the stroke analysis was 7860. Mean age of the 
participants was 56 years at baseline and 30% were women.  A flow chart for sample selection is 
provided in eAppendix 1; http://links.lww.com/EDE/B213. 
 During surveillance, we identified 950 incident or recurrent non-fatal coronary heart disease 
cases and 118 incident or recurrent non-fatal stroke cases using Whitehall-ascertainment methods. The 
corresponding figures for HES ascertainment were similar but slightly lower (926 and 107). In Table 1 
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we show that using Whitehall-ascertainment as the referent the sensitivity of HES-ascertainment for 
coronary heart disease was 70% and the positive predictive value was 72%. These statistics were 
somewhat higher for men (72% and 75%) than for women (61% and 59%). Specificity and negative 
predictive values varied between 93% and 98% in the total cohort and in age- and sex-groups. 
Exclusion of participants with prevalent disease had little impact on these results. In Table 2 we see 
that the pattern of results for stroke was similar. Specificity and negative predictive value was 99% or 
higher in all cases. 
 In analyses for non-fatal incident or recurrent coronary heart disease stratified by risk factor 
status, with one exception, sensitivity exceeded 65% and the positive predictive value exceeded 70% 
(eAppendix 2; http://links.lww.com/EDE/B213). Specificity and negative predictive value varied 
between 93% and 98%. Sensitivity improved over time (eAppendix 3; 
http://links.lww.com/EDE/B213): for coronary heart disease it was 52% between Clinics 3 and 4, but 
78% between Clinics 5 and 6. For stroke, sensitivity was 64% in the first period and 75% between 
subsequent Clinics 4 and 5. Irrespective of the period of follow-up, specificity and negative predictive 
value were high (≥96%).  
The associations of risk factors with coronary heart disease and stroke did not differ between 
Whitehall and HES-ascertained endpoints (eAppendices 4 and 5; http://links.lww.com/EDE/B213). 
Supplementary analyses on the comparison of Whitehall and HES ascertainment for non-fatal or fatal 
cardiovascular disease as the outcome are provided in eAppendices 6 to 9; 
http://links.lww.com/EDE/B213. For Whitehall ascertainment, death records identified 69 new 
coronary heart disease cases (total N for cases=1019) and six new stroke cases (total N=124). The 
corresponding figures for HES ascertainment were 72 (total N=998) and 15 (total N=122). The 
agreement between the two methods improved slightly. 
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DISCUSSION 
Our analyses support the validity of cardiovascular disease ascertainment using linkage to HES, the 
UK’s nationwide hospital events database, by showing good agreement with high resolution data 
collected in the Whitehall II cohort.  The estimates of associations between classic risk factor and 
cardiovascular diseases were also very similar for each of the two ascertainment methods, as would be 
expected given the high specificity and apparently non-differential sensitivity.
9
  
 In validation studies of electronic records, the reference standard has varied, including for 
example general practitioner (physician)-verified events, patient self-report based on interviews, 
independent clinical registries, laboratory information system databases, pathology registries, 
biobanks, and autopsy reports.
10-12
 We used serial biomedical evaluations combined with clinical data 
tracing as the gold standard in a context of an unusually well-characterised cohort study. This 
comparison of the traditional resource-intensive ascertainment method used in longitudinal cohort 
studies
1,2
 with the low-cost alternative data linkage method indicates that, at least in the UK, linkage 
with electronic health records is suitable for detecting major cardiovascular disease events for many 
epidemiologic purposes. 
 Thirty percent of the Whitehall ascertained incident and recurrent non-fatal coronary heart 
disease cases were not identified by HES ascertainment. The corresponding percentage for stroke was 
29%. While some of these cases are likely to be due to the limited coverage of HES data, especially in 
the early years of the follow-up, some of the uncaptured cases also included angina events that did not 
result in hospitalization.
13
 
A total of 28% of the coronary heart disease and 21% of stroke cases that were captured by HES 
were not captured by Whitehall ascertainment. These cases are likely to be true cases rather than errors 
in HES database. Whitehall ascertainment may miss cases if the participant does not attend a clinical 
examination or does not respond to questionnaires that trigger additional corroboration against general 
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practitioner notes and manual retrieval of medical records from hospitals.  A further limitation of 
Whitehall stroke ascertainment was the absence of brain scanning. 
 The electronic health records are integral to the new precision medicine in cardiology
6 
and 
studies evaluating such databases for large-scale research support their utility.
10-12
 In the UK Biobank, 
for example, linkage of over 330,000 study members to records from HES has been shown to be both a 
pragmatic method to identify cardiovascular disease and one that minimizes participant burden.
5
 Our 
findings suggest that use of UK HES records is a valid method for coronary heart disease and stroke 
ascertainment for cohort studies examining risk factor–disease associations. It offers a low-cost 
alternative to  traditional ascertainment through biomedical screening and tracing processes.  
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13 TABLE 1. Cross-classification and Validation of Non-Fatal Incident or Recurrent Coronary Heart Disease Defined Using HES-ascertainment with Whitehall-
ascertainment as the Reference in the Total Cohort and According to Sub-groups 
 
   
 
Whitehall-
ascertainment 
HES-
ascertainment 
Percent (95% confidence interval) 
   
Case 
 
Non-
case 
 
Sensitivity  
 
Specificity 
Positive predictive 
value 
Negative predictive 
value 
         
Total  (N=7855) Case 665 285 70 (67-73) 96 (96-96) 72 (69-75) 96 (96-96) 
  Non-case 261 6644     
         
Gender  Men (N=5466) Case 542 206 72 (69-76) 96 (96-96) 75 (72-79) 96 (96-96) 
 Non-case 176 4542     
        
Women 
(N=2389) 
Case 123 79 61 (54-68) 96 (95-97) 59 (52-66) 96 (96-97) 
 Non-case 85 2102     
         
Age at start of 
follow-up 
 <55 years 
(N=3795) 
Case 189 101 65 (59-71) 98 (97-98) 72 (66-77) 97 (97-98) 
 Non-case 75 3430     
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14 55 – 59 years 
(N=1687) 
Case 163 69 70 (64-76) 96 (95-97) 76 (70-82) 95 (94-96) 
 Non-case 51 1404     
        
≥ 60 years 
(N=2373) 
Case 313 115 73 (69-77) 93 (92-94) 70 (65-74) 94 (93-95) 
 Non-case 135 1810     
         
Total, excluding 
prevalent CHD 
 (N=7286) Case 470 215 69 (65-72) 97 (97-97) 70 (67-74) 97 (97-97) 
 Non-case 198 6403     
         
CHD indicates coronary heart disease. 
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 TABLE 2. Cross-classification and Validation of Non-fatal Incident or Recurrent Stroke Defined Using HES-ascertainment with Whitehall-ascertainment as 
the Reference in the Total Cohort and According to Sub-groups 
 
   
 
Whitehall-
ascertainm
ent  
HES-ascertainment Percent (95% confidence interval) 
   
Case 
 
Non-case 
 
Sensitivity  
 
Specificity 
Positive 
predictive value 
Negative 
predictive value 
         
Total  (N=7860) Case 84 34 71 (62-79) 100 (100-100) 79 (70-86) 100 (99-100) 
  Non-case 23 7719     
         
Gender  Men (N=5470) Case 61 26 70 (59-80) 100 (100-100) 80 (70-89) 100 (99-100) 
 Non-case 15 5368     
        
Women (N=2390) Case 23 8 74 (55-88) 100 (99-100) 74 (55-88) 100 (99-100) 
 Non-case 8 2351     
         
Age at start of follow-up  <60 years (N=5486) Case 30 17 64 (49-77) 100 (100-100) 73 (57-86) 100 (100-100) 
 Non-case 11 5428     
        
≥60 years (N=2374) Case 54 17 76 (65-85) 100 (99-100) 82 (70-90) 99 (99-100) 
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  Non-case 12 2291     
         
Total, excluding 
prevalent stroke 
 (N=7839) Case 82 33 71 (62-79) 100 (100-100) 78 (69-86) 100 (99-100) 
 Non-case 23 7701     
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